Availability, price, and affordability of WHO priority maternal and child health medicine in public health facilities of Dessie, north-East Ethiopia
Tóm tắt
Access to health care is a fundamental human right, and the provision of affordable, high-quality, and appropriate medicines for maternal and child health is a vital component of a well-functioning health system. The study assessed the availability, price, and affordability of WHO priority maternal and child medicines in public health facilities, Dessie, North-East Ethiopia. A retrospective cross-sectional study design was conducted in Dessie town from November 2018 to February 2019. A standard checklist adapted from the Logistics Indicator Assessment Tool and WHO/HAI was used to collecting data on the availability, affordability, and price of 45 priority life-saving medicines from eight public health centers and two public hospitals. Descriptive statistics (percent and median) were computed for availability and prices. Affordability was reported in terms of the daily wage of the lowest-paid unskilled government worker. Twenty-two medicines were not found at all in public health facilities. The overall availability of WHO priority maternal and child medicines was 34.02%. The mean number of stock-outs was 3.9, and the mean number was 128.9 days. The mean average point availability was 33.5%, and 7 medicines stock out on the days of assessment. From WHO priority maternal and child medicines, 4 (40%) of the products were unaffordable and 5 (55.5%) had higher prices than international prices. Ceftriaxone 1 g, ceftriaxone 500 mg, and hydralazine 20 mg injection required wages of 6.58, 8.01, and 5.02 to cover specific maternal health problems respectively. The median price ratio of priority lifesaving maternal and child medicines in public health facilities ranged from 0.65 to 3.19. The average mean period and point mean availability was very low. The available products were encountered with a high number of stock-outs and unaffordable. The strict control of inventory is recommended to have a steady supply of these essential medicines and improve the quality of health services.
Tài liệu tham khảo
Margolis L, Kotch J. Tracing the historical foundations of maternal and child health to contemporary times. Matern Child Health. 2012;25:11.
World Health Organization. Equitable access to essential medicines: a framework for collective action. World Health Organization; 2004. Available at: https://apps.who.int/iris/bitstream/handle/10665/68571/WHO_EDM_2004.4_rus.pdf.
Hill S, Yang A, Bero L. Priority medicines for maternal and child health: a global survey of national essential medicines lists. PLoS One. 2012;7(5):e38055.
Dieleman JL, Campbell M, Chapin A, Eldrenkamp E, Fan VY, Haakenstad A, Kates J, Li Z, Matyasz T, Micah A, Reynolds A. Future and potential spending on health 2015–40: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries. Lancet. 2017;389(10083):2005–30.
Leisinger KM, Garabedian LF, Wagner AK. Improving access to medicines in low and middle income countries: corporate responsibilities in context. Southern Med Rev. 2012;5(2):3.
World Health Organization. Workshop on ensuring access to priority medicines for mothers and children, Manila, Philippines, 15 to 17 august 2011: report. Manila: WHO Regional Office for the Western Pacific; 2011.
UNICEF. State of the World's Children: Celebrating 20 Years of the Convention on the Rights of the Child. Unicef; 2009. Available at: https://books.google.com/books?hl=en&lr=&id=TsSsUZ990HUC&oi=fnd&pg=PA1&dq=7.%09UNICEF..+State+of+the+World%27s+Children:+Celebrating+20+Years+of+the+Convention+on+the+Rights+of+the+Child.+Unicef%3B+2009.&ots=uWzXH_Hkve&sig=aQvjcp5NVhT2O8Bu1xieI9QK6lg.
Bryce J, Requejo JH. Tracking progress in maternal, newborn and child survival: the 2008 report. New York: UNICEF; 2008.
World Health Organization. World health statistics 2016: monitoring health for the SDGs sustainable development goals. World Health Organization; 2016. Available at: https://books.google.com/books?hl=en&lr=&id=-A4LDgAAQBAJ&oi=fnd&pg=PP1&dq=9.%09World+Health+Organization.+World+health+statistics+2016:+monitoring+health+for+the+SDGs+sustainable+development+goals.+World+Health+Organization%3B+2016+Jun+8.&ots=dbql3RcowB&sig=ZA91OeUeORkGBJZ60Zam6lKSDgg.
World Health Organization, World Health Organization. Ageing, Life Course Unit. WHO global report on falls prevention in older age. World Health Organization; 2008. Available at: https://books.google.com/books?hl=en&lr=&id=ms9o2dvfaQkC&oi=fnd&pg=PA1&dq=10.%09World+Health+Organization,+World+Health+Organization.+Ageing,+Life+Course+Unit.+WHO+global+report+on+falls+prevention+in+older+age.+World+Health+Organization%3B+2008.&ots=5KF0LGWM_X&sig=GLc8Ub3W8zytoPb2srZfwrPqYo.
United Nations Development Group, United Nations. Statistical Division. Indicators for monitoring the millennium development goals: definitions, rationale, concepts and sources. United Nations Publications; 2003. Available at: http://mdgs.un.org/unsd/mdg/Resources/Attach/Indicators/HandbookEnglish.pdf.
Mhlanga BS, Suleman F. Price, availability and affordability of medicines. Afr J Prim Health Care Fam Med. 2014;6(1):1–6.
Zarocostas J. Better access to drugs could save 10 million lives a year, says UN expert. BMJ. 2007;335(7621):635.
Chandani Y, Noel M, Pomeroy A, Andersson S, Pahl MK, Williams T. Factors affecting availability of essential medicines among community health workers in Ethiopia, Malawi, and Rwanda: solving the last mile puzzle. Am J Trop Med Hyg. 2012;87(5_Suppl):120–6.
Central Statistics Agency Ethiopia. Central statistics agency of Ethiopia report of the population and housing census. 2007. Available at: http://www.csa.gov.et/census-report/complete-report/census-2007.
World Health Organazation. Priority life-saving medicines for women and children. 2012. Available at: https://www.who.int/reproductivehealth/publications/general/emp_mar2012.1/en/.
Gelders S, Ewen M, Noguchi N, Laing R. Price, availability and affordability: an international comparison of chronic disease medicines. Cairo: World Health Organization and Health Action International; 2006.
Management Sciences for Health. International medical products price guide, 2015 edition. 2016. Available at: http://apps.who.int/medicinedocs/documents/s21982en/s21982en.pdf.
Auditable Pharmaceutical Transactions and Services Trainers’ Guide, last version. 2018. Available at https:// www.biorxiv.org/content/biorxiv/early/2018/07/26/378000.full.pdfT.
Robertson J, Forte G, Trapsida JM, Hill S. What essential medicines for children are on the shelf? Available at: https://www.scielosp.org/article/bwho/2009.v87n3/231-237.
Ethiopia CSA. Ethiopia demographic and health survey. Central statistical agency. Central statistical Agency of Ethiopia: Addis Ababa, Ethiopia; 2012.
World Health Organization. Child growth standards. Geneva: World Health Organization. Available at: https://www.who.int/childgrowth/en/.
Ranabhat CL, Atkinson J, Park MB, Kim CB, Jakovljevic M. The influence of universal health coverage on life expectancy at birth (LEAB) and healthy life expectancy (HALE): a multi-country cross-sectional study. Front Pharmacol. 2018;9:960.
Nyanwura EM, Esena RK. Essential medicines availability and affordability: a case study of the top ten registered diseases in Builsa District of Ghana. Int J Sci Technol Res. 2013;2(8):208–19.
Abrha S, Tadesse E, Atey TM, Molla F, Melkam W, Masresha B, Gashaw S, Wondimu A. Availability and affordability of priority life-saving medicines for under-five children in health facilities of Tigray region, northern Ethiopia. BMC Pregnancy Childbirth. 2018;18(1):464.
Sautenkova N, Ferrario A, Bolokhovets G, Kanavos P. Availability and affordability of medicines and assessment of quality systems for prescription of medicines in the Republic of Moldova; 2012.
Prinja S, Bahuguna P, Tripathy JP, Kumar R. Availability of medicines in public sector health facilities of two north Indian states. BMC Pharmacol Toxicol. 2015;16(1):43.
Bazargani YT, Ewen M, de Boer A, Leufkens HG, Mantel-Teeuwisse AK. Essential medicines are more available than other medicines around the globe. PLoS One. 2014;9(2):e87576.
Anson A, Ramay B, de Esparza AR, Bero L. Availability, prices and affordability of the World Health Organization’s essential medicines for children in Guatemala. Glob Health. 2012;8(1):22.
Federal Democratic Republic of Ethiopia. Ministry of Health. Health Sector Development Program IV. Addis Ababa, Ethiopia: Ethiopian Central Statistical Authority; 2010.
Kondro W. Priority medicines for maternal and child health. Can Med Assoc J. 2011;183(7):E371.
Jakovljevic MB. The key role of the leading emerging BRIC markets in the future of global health care. Serbian J Exp Clin Res. 2014;15(3):139–43.
Fentie M, Fenta A, Moges F, Oumer H, Belay S, Sebhat Y, Atinafu T, Mekonnen T, Somasundaram J. Availability of essential medicines and inventory management practice in primary public health facilities of Gondar town, north West Ethiopia. J PharmaSciTech. 2015;4(2):54–6.
Kibira D, Kitutu FE, Merrett GB, Mantel-Teeuwisse AK. Availability, prices and affordability of UN Commission’s lifesaving medicines for reproductive and maternal health in Uganda. J Pharm Policy Pract. 2017;10(1):1–8.
Wagenaar BH, Gimbel S, Hoek R, Pfeiffer J, Michel C, Manuel JL, Cuembelo F, Quembo T, Afonso P, Gloyd S, Sherr K. Stock-outs of essential health products in M ozambique–longitudinal analyses from 2011 to 2013. Tropical Med Int Health. 2014;19(7):791–801.
Getahun W, Tadeg H, Ejigu E, Korra A. Health facility assessment on availability of the 13 reproductive, maternal, newborn, and child health commodities prioritized by the UN Commission on life-saving Commodities for Women and Children. United States Agency for International Development: Arlington; 2015.
Federal Democratic Republic of Ethiopia, Ministry of Health. Country Implementation Plan for Prioritized Life-Saving Commodities for Women and Children. Addis Ababa, Ethiopia: Federal Ministry of Health; 2013. Available at: http://supplypromises.org/wp-content/uploads/2014/09/ETHIOPIA-UNCoLSC-.pdf.
Yang H, Dib HH, Zhu M, Qi G, Zhang X. Prices, availability and affordability of essential medicines in rural areas of Hubei Province, China. Health Policy Plan. 2010;25(3):219–29.
Van Mourik MS, Cameron A, Ewen M, Laing RO. Availability, price and affordability of cardiovascular medicines: a comparison across 36 countries using WHO/HAI data. BMC Cardiovasc Disord. 2010;10(1):25.
Jakovljevic MM, Ogura S. Health economics at the crossroads of centuries–from the past to the future. Front Public Health. 2016;4:115.
Jakovljevic MM. Comparison of historical medical spending patterns among the BRICS and G7. J Med Econ. 2016;19(1):70–6.
Sado E, Sufa A. Availability and affordability of essential medicines for children in the Western part of Ethiopia: implication for access. BMC Pediatr. 2016;16(1):40.
Wang X, Fang Y, Yang S, Jiang M, Yan K, Wu L, Lv B, Shen Q. Access to paediatric essential medicines: a survey of prices, availability, affordability and price components in Shaanxi Province, China. PLoS One. 2014;9(3):e90365.
Jakovljevic M, Jakab M, Gerdtham U, McDaid D, Ogura S, Varavikova E, Merrick J, Adany R, Okunade A, Getzen TE. Comparative financing analysis and political economy of noncommunicable diseases. J Med Econ. 2019;22(8):722–7.